Aigen Investment Management LP Buys New Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Aigen Investment Management LP acquired a new stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund acquired 97,289 shares of the pharmacy operator’s stock, valued at approximately $872,000.

Other institutional investors have also recently made changes to their positions in the company. Iron Horse Wealth Management LLC grew its stake in shares of Walgreens Boots Alliance by 162.5% in the second quarter. Iron Horse Wealth Management LLC now owns 2,100 shares of the pharmacy operator’s stock worth $25,000 after purchasing an additional 1,300 shares during the last quarter. Blue Trust Inc. increased its stake in shares of Walgreens Boots Alliance by 87.0% during the second quarter. Blue Trust Inc. now owns 2,324 shares of the pharmacy operator’s stock valued at $28,000 after buying an additional 1,081 shares during the period. Continuum Advisory LLC raised its holdings in shares of Walgreens Boots Alliance by 71.2% during the second quarter. Continuum Advisory LLC now owns 2,453 shares of the pharmacy operator’s stock valued at $30,000 after acquiring an additional 1,020 shares in the last quarter. Sentry Investment Management LLC purchased a new stake in Walgreens Boots Alliance in the third quarter worth $30,000. Finally, Eastern Bank bought a new stake in Walgreens Boots Alliance in the third quarter valued at $33,000. Hedge funds and other institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Price Performance

Shares of NASDAQ WBA opened at $9.01 on Wednesday. Walgreens Boots Alliance, Inc. has a twelve month low of $8.22 and a twelve month high of $27.05. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.37 and a current ratio of 0.68. The company has a 50 day moving average of $9.18 and a 200 day moving average of $12.08.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Tuesday, October 15th. The pharmacy operator reported $0.39 EPS for the quarter, beating the consensus estimate of $0.36 by $0.03. Walgreens Boots Alliance had a positive return on equity of 14.23% and a negative net margin of 5.85%. The company had revenue of $37.50 billion for the quarter, compared to analysts’ expectations of $35.75 billion. During the same period last year, the firm posted $0.67 earnings per share. Walgreens Boots Alliance’s revenue was up 5.9% compared to the same quarter last year. As a group, equities research analysts predict that Walgreens Boots Alliance, Inc. will post 1.53 EPS for the current fiscal year.

Walgreens Boots Alliance Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, December 12th. Investors of record on Monday, November 18th will be issued a $0.25 dividend. This represents a $1.00 annualized dividend and a yield of 11.10%. The ex-dividend date of this dividend is Monday, November 18th. Walgreens Boots Alliance’s dividend payout ratio is currently -9.99%.

Wall Street Analyst Weigh In

WBA has been the subject of several research analyst reports. JPMorgan Chase & Co. dropped their target price on shares of Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating for the company in a research report on Friday, August 30th. TD Cowen lowered their price objective on shares of Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating for the company in a report on Tuesday, October 22nd. Jefferies Financial Group decreased their target price on Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating for the company in a research report on Wednesday, October 23rd. Morgan Stanley reduced their price target on Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating on the stock in a research note on Friday, October 11th. Finally, Truist Financial lowered their price objective on Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating for the company in a research report on Monday, October 7th. Four analysts have rated the stock with a sell rating, nine have issued a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat.com, Walgreens Boots Alliance presently has a consensus rating of “Hold” and an average price target of $12.88.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.